Meyka Pro banner
Bausch + Lomb Corporation

Bausch + Lomb Corporation (BLCO) Stock Overview

Explore Bausch + Lomb Corporation’s financial performance, market position, analyst ratings, and future outlook.

BLCONYSE
HealthcareMedical - Instruments & Supplies
$16.17
$0.19(1.19%)
U.S. Market opens in 14h 26m

Bausch + Lomb Corporation (BLCO)

Meyka AI Score

Z

Key Financials

Market Cap5.8B
P/E Ratio-26.12
EPS (TTM)$0.65
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$16.22
3 Months$22.62
1 Year Target$15.98

BLCO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Bausch + Lomb Corporation (NYSE: BLCO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bausch + Lomb Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BLCO on the NYSE shows an RSI of 52.06, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.98 for the NYSE listing.

Key metrics behind Bausch + Lomb Corporation's NYSE-traded stock include a P/E ratio of -26.12 and a market capitalization of 5.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BLCO on the NYSE.

Price Performance (NYSE: BLCO)

1-Day Change
1.19%
5-Day Change
-3.12%
1-Month Change
4.05%
3-Month Change
2.21%
6-Month Change
-4.77%
Year-to-Date (YTD) Change
-5.33%
1-Year Change
15.75%
3-Year Change
-17.71%
5-Year Change
-19.15%
All-Time (Max) Change
-19.15%

Contact Information

905 695 7700
520 Applewood Crescent, Vaughan, ON, L4K 4B4

Company Facts

130,000 Employees
IPO DateMay 6, 2022
CountryCA
Actively Trading

Frequently Asked Questions